abstract |
The invention concerns pharmaceutical compositions for the treatment of hyperproliferative diseases of the epidermis such as cancers and psoriasis, as well as for the treatment of aging of the epidermis. The active ingredient can be nicotinamide (NA), cyclic adenosine diphosphate-ribose (cADPR) or a combination of the two. |